Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Syndax Pharmaceuticals (SNDX) Other financing activities: 2014-2020

Historic Other financing activities for Syndax Pharmaceuticals (SNDX) over the last 7 years, with Dec 2020 value amounting to $1,000.

  • Syndax Pharmaceuticals' Other financing activities rose 16.46% to $92,000 in Q1 2022 from the same period last year, while for Mar 2022 it was $13,000, marking a year-over-year decrease of 18.75%. This contributed to the annual value of $1,000 for FY2020, which is 99.45% down from last year.
  • Per Syndax Pharmaceuticals' latest filing, its Other financing activities stood at $1,000 for FY2020, which was down 99.45% from $182,000 recorded in FY2019.
  • In the past 5 years, Syndax Pharmaceuticals' Other financing activities registered a high of $198,000 during FY2018, and its lowest value of -$4,000 during FY2016.
  • Over the past 3 years, Syndax Pharmaceuticals' median Other financing activities value was $182,000 (recorded in 2019), while the average stood at $127,000.
  • As far as peak fluctuations go, Syndax Pharmaceuticals' Other financing activities crashed by 100.32% in 2016, and later surged by 2,525.00% in 2017.
  • Syndax Pharmaceuticals' Other financing activities (Yearly) stood at -$4,000 in 2016, then surged by 2,525.00% to $97,000 in 2017, then spiked by 104.12% to $198,000 in 2018, then decreased by 8.08% to $182,000 in 2019, then crashed by 99.45% to $1,000 in 2020.